Paper · 40213562
Comprehensive pan-cancer analysis indicates key gene of p53-independent apoptosis is a novel biomarker for clinical application and chemotherapy in colorectal cancer.
Yan J and 3 others. Front Immunol, 2025. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comprehensive pan-cancer analysis indicates key gene of p53-independent apoptosis is a novel biomarker for clinical application and chemotherapy in colorectal cancer. Papers, record 40213562. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40213562
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive pan-cancer analysis indicates key gene of p53-independent apoptosis is a novel biomarker for clinical application and chemotherapy in colorectal cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Apoptosis | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Nuclear Proteins | Major topic |
| Humans | |
| Gene Expression Regulation, Neoplastic | |
| Tumor Microenvironment | |
| Drug Resistance, Neoplasm | |
| Prognosis | |
| Cell Line, Tumor |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,406,595 | Applications of single‑cell omics and spatial transcriptomics technologies in gastric cancer (Review). | Oncol Lett | 2024 | https://conductscience.org/library/papers/38406595 | PubMed |
| 2 | 39,267,056 | Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39267056 | PubMed |
| 3 | 36,816,981 | Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/36816981 | PubMed |
| 4 | 30,566,255 | Tissue microenvironment initiates an immune response to structural components of Staphylococcus aureus. | Exp Dermatol | 2019 | https://conductscience.org/library/papers/30566255 | PubMed |
| 5 | 30,389,923 | Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. | Nat Commun | 2018 | https://conductscience.org/library/papers/30389923 | PubMed |
| 6 | 38,315,776 | The Web-Based Portal SpatialTME Integrates Histological Images with Single-Cell and Spatial Transcriptomics to Explore the Tumor Microenvironment. | Cancer Res | 2024 | https://conductscience.org/library/papers/38315776 | PubMed |
| 7 | 26,656,090 | Correlating chemical sensitivity and basal gene expression reveals mechanism of action. | Nat Chem Biol | 2016 | https://conductscience.org/library/papers/26656090 | PubMed |
| 8 | 33,726,687 | A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. | BMC Cancer | 2021 | https://conductscience.org/library/papers/33726687 | PubMed |
| 9 | 30,668,768 | Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition. | Neuro Oncol | 2019 | https://conductscience.org/library/papers/30668768 | PubMed |
| 10 | 33,179,754 | TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33179754 | PubMed |
1 to 10 of 33
See all 33 referencesCited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,724,844 | Microplastics and nanoplastics-related genes signature predicts prognosis in pancreatic ductal adenocarcinoma and functional validation of interleukin 1 alpha. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724844 | PubMed |
| 42,572,974 | Comprehensive Pan-Cancer Analysis of ABCA1: Insights From Multi-Omics Data and Exploratory Validation in Esophageal Squamous Cell Carcinoma. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42572974 | PubMed |
| 42,535,370 | Unveiling the role of spatial transcriptomics in the analysis of the tumor immune microenvironment (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42535370 | PubMed |
| 42,421,031 | Regulated cell death plasticity in cancer: thresholds, reversibility, and therapeutic failure. | J Transl Med | 2026 | https://conductscience.org/library/papers/42421031 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SLFN11 | 91,607 | PubTator's text mining | https://conductscience.org/library/genes/91607 | NCBI Gene |
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40213562
GET https://conductscience.org/api/papers/v1/40213562/references?page=2